These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 28668079

  • 1. Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis.
    Fang L, Wang Y, Zheng Q, Yang T, Zhao P, Zhao H, Zhang Q, Zhao Y, Qi F, Li K, Chen Z, Li J, Zhang N, Fan Y, Wang L.
    BMC Complement Altern Med; 2017 Jul 01; 17(1):346. PubMed ID: 28668079
    [Abstract] [Full Text] [Related]

  • 2. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
    Zhao PY, Wang YQ, Liu XH, Zhu YJ, Zhao H, Zhang QX, Qi F, Li JL, Zhang N, Fan YP, Li KN, Zhao YY, Lei JF, Wang L.
    J Ethnopharmacol; 2018 May 10; 217():36-48. PubMed ID: 29428242
    [Abstract] [Full Text] [Related]

  • 3. Zuo-Gui and You-Gui pills, two traditional Chinese herbal formulas, downregulated the expression of NogoA, NgR, and RhoA in rats with experimental autoimmune encephalomyelitis.
    Kou S, Zheng Q, Wang Y, Zhao H, Zhang Q, Li M, Qi F, Fang L, Liu L, Ouyang J, Zhao H, Wang L.
    J Ethnopharmacol; 2014 Dec 02; 158 Pt A():102-12. PubMed ID: 25448504
    [Abstract] [Full Text] [Related]

  • 4. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Zheng Q, Yang T, Fang L, Liu L, Liu H, Zhao H, Zhao Y, Guo H, Fan Y, Wang L.
    BMC Complement Altern Med; 2015 Mar 12; 15():60. PubMed ID: 25887665
    [Abstract] [Full Text] [Related]

  • 5. Anti-apoptotic efficacy of Qingnao Yizhi formula in hypoxia/reoxygenation primary cortical neurons through the promotion of synaptic plasticity by modulating the NogoA-Nogo receptor/Rho-Rho kinase signaling pathway.
    Qin X, Liu Y, Wu Y, Wang S, Wu H, Zhu J.
    J Tradit Chin Med; 2021 Feb 12; 41(1):59-67. PubMed ID: 33522198
    [Abstract] [Full Text] [Related]

  • 6. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
    Theotokis P, Touloumi O, Lagoudaki R, Nousiopoulou E, Kesidou E, Siafis S, Tselios T, Lourbopoulos A, Karacostas D, Grigoriadis N, Simeonidou C.
    J Neuroinflammation; 2016 Oct 11; 13(1):265. PubMed ID: 27724971
    [Abstract] [Full Text] [Related]

  • 7. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Ji X, Liu H, An C, Wang Y, Zhao H, Zhang Q, Li M, Qi F, Chen Z, Wang X, Wang L.
    J Ethnopharmacol; 2016 Jul 01; 187():123-33. PubMed ID: 27106785
    [Abstract] [Full Text] [Related]

  • 8. Bu-Shen-Yi-Sui Capsule, an Herbal Medicine Formula, Promotes Remyelination by Modulating the Molecular Signals via Exosomes in Mice with Experimental Autoimmune Encephalomyelitis.
    Zhao PY, Ji J, Liu XH, Zhao H, Xue B, Jin LY, Fan YP, Zhao WJ, Wang L.
    Oxid Med Cell Longev; 2020 Jul 01; 2020():7895293. PubMed ID: 32774683
    [Abstract] [Full Text] [Related]

  • 9. Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.
    Yang T, Zheng Q, Zhao H, Zhang QX, Li M, Qi F, Li KN, Fang L, Wang L, Fan YP.
    Chin J Integr Med; 2016 Dec 01; 22(12):932-940. PubMed ID: 26919831
    [Abstract] [Full Text] [Related]

  • 10. Matrine Treatment Blocks NogoA-Induced Neural Inhibitory Signaling Pathway in Ongoing Experimental Autoimmune Encephalomyelitis.
    Kan QC, Zhang HJ, Zhang Y, Li X, Xu YM, Thome R, Zhang ML, Liu N, Chu YJ, Zhang GX, Zhu L.
    Mol Neurobiol; 2017 Dec 01; 54(10):8404-8418. PubMed ID: 27933584
    [Abstract] [Full Text] [Related]

  • 11. Effect of Naoluoxintong on the NogoA/RhoA/ROCK pathway by down-regulating DNA methylation in MCAO rats.
    Hong L, Chen W, He L, Tan H, Peng D, Zhao G, Shi X, Wang L, Liu M, Jiang H.
    J Ethnopharmacol; 2021 Dec 05; 281():114559. PubMed ID: 34461189
    [Abstract] [Full Text] [Related]

  • 12. Constraint-Induced Movement Therapy Promotes Neural Remodeling and Functional Reorganization by Overcoming Nogo-A/NgR/RhoA/ROCK Signals in Hemiplegic Cerebral Palsy Mice.
    Liu LR, Wang YX, He L, Xu YX, Huang JY, Peng TT, Yang XB, Pan J, Tang HM, Xu KS.
    Neurorehabil Neural Repair; 2021 Feb 05; 35(2):145-157. PubMed ID: 33410385
    [Abstract] [Full Text] [Related]

  • 13. BDNF/PI3K/Akt and Nogo-A/RhoA/ROCK signaling pathways contribute to neurorestorative effect of Houshiheisan against cerebral ischemia injury in rats.
    Chang J, Yao X, Zou H, Wang L, Lu Y, Zhang Q, Zhao H.
    J Ethnopharmacol; 2016 Dec 24; 194():1032-1042. PubMed ID: 27833029
    [Abstract] [Full Text] [Related]

  • 14. Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.
    Zha Z, Gao YF, Ji J, Sun YQ, Li JL, Qi F, Zhang N, Jin LY, Xue B, Yang T, Fan YP, Zhao H, Wang L.
    Oxid Med Cell Longev; 2021 Dec 24; 2021():5521503. PubMed ID: 33815654
    [Abstract] [Full Text] [Related]

  • 15. The Bu Shen Yi Sui Formula Promotes Axonal Regeneration via Regulating the Neurotrophic Factor BDNF/TrkB and the Downstream PI3K/Akt Signaling Pathway.
    Zheng Q, Liu L, Liu H, Zheng H, Sun H, Ji J, Sun Y, Yang T, Zhao H, Qi F, Li K, Li J, Zhang N, Fan Y, Wang L.
    Front Pharmacol; 2019 Dec 24; 10():796. PubMed ID: 31379571
    [Abstract] [Full Text] [Related]

  • 16. Bu Shen Yi Sui Capsules Promote Remyelination by Regulating MicroRNA-219 and MicroRNA-338 in Exosomes to Promote Oligodendrocyte Precursor Cell Differentiation.
    Ji J, Sun YQ, Zha Z, Xue B, Li JL, Jin LY, Qi F, Zhang N, Zhao H, Fan YP, Wang L.
    Evid Based Complement Alternat Med; 2022 Dec 24; 2022():3341481. PubMed ID: 35463062
    [Abstract] [Full Text] [Related]

  • 17. Silencing Nogo-A promotes functional recovery in demyelinating disease.
    Yang Y, Liu Y, Wei P, Peng H, Winger R, Hussain RZ, Ben LH, Cravens PD, Gocke AR, Puttaparthi K, Racke MK, McTigue DM, Lovett-Racke AE.
    Ann Neurol; 2010 Apr 24; 67(4):498-507. PubMed ID: 20437585
    [Abstract] [Full Text] [Related]

  • 18. Exercise modulates the levels of growth inhibitor genes before and after multiple sclerosis.
    Shahidi SH, Kordi MR, Rajabi H, Malm C, Shah F, Quchan ASK.
    J Neuroimmunol; 2020 Apr 15; 341():577172. PubMed ID: 32028123
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model.
    Singh I, Samuvel DJ, Choi S, Saxena N, Singh AK, Won J.
    Immunology; 2018 Jul 15; 154(3):434-451. PubMed ID: 29331024
    [Abstract] [Full Text] [Related]

  • 20. The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway.
    Fang Y, Wang J, Yao L, Li C, Wang J, Liu Y, Tao X, Sun H, Liao H.
    J Neuroinflammation; 2018 Jul 20; 15(1):210. PubMed ID: 30029608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.